Search research articles
Contact Us
Filters
Showing results (151-160 of 174) with videos related to
Page
of 18
Sort By:
The Lancet. Oncology
|
September 17, 2023
Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study
Niels W C J van de Donk, Monique C Minnema, Bronno van der Holt, et al.
Nature Medicine
|
April 6, 2026
Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial
Francesca Gay, Wilfried Roeloffzen, Meletios A Dimopoulos, et al.
Leukemia
|
May 4, 2018
Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network
Heinz Ludwig, Michel Delforge, Thierry Facon, et al.
Hemasphere
|
October 15, 2025
European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma
Niccolò Bolli, Mattia D'Agostino, Tina Bagratuni, et al.
Leukemia
|
March 25, 2022
LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma
Maria-Victoria Mateos, Katja Weisel, Valerio De Stefano, et al.
The Lancet. Haematology
|
November 10, 2021
COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network
Heinz Ludwig, Pieter Sonneveld, Thierry Facon, et al.
Transplantation and Cellular Therapy
|
March 20, 2022
ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Multiple Myeloma
Binod Dhakal, Nina Shah, Ankit Kansagra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 23, 2022
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project
Mattia D'Agostino, David A Cairns, Juan José Lahuerta, et al.
Nature Reviews. Clinical Oncology
|
July 7, 2025
EHA-EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma
Meletios A Dimopoulos, Evangelos Terpos, Mario Boccadoro, et al.
Blood Cancer Discovery
|
June 2, 2022
Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
Faith E Davies, Charlotte Pawlyn, Saad Z Usmani, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 174) with videos related to
Sort By:
Page
of 18
The Lancet. Oncology
|
September 17, 2023
Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study
Niels W C J van de Donk, Monique C Minnema, Bronno van der Holt, et al.
Nature Medicine
|
April 6, 2026
Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial
Francesca Gay, Wilfried Roeloffzen, Meletios A Dimopoulos, et al.
Leukemia
|
May 4, 2018
Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network
Heinz Ludwig, Michel Delforge, Thierry Facon, et al.
Hemasphere
|
October 15, 2025
European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma
Niccolò Bolli, Mattia D'Agostino, Tina Bagratuni, et al.
Leukemia
|
March 25, 2022
LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma
Maria-Victoria Mateos, Katja Weisel, Valerio De Stefano, et al.
The Lancet. Haematology
|
November 10, 2021
COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network
Heinz Ludwig, Pieter Sonneveld, Thierry Facon, et al.
Transplantation and Cellular Therapy
|
March 20, 2022
ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Multiple Myeloma
Binod Dhakal, Nina Shah, Ankit Kansagra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 23, 2022
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project
Mattia D'Agostino, David A Cairns, Juan José Lahuerta, et al.
Nature Reviews. Clinical Oncology
|
July 7, 2025
EHA-EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma
Meletios A Dimopoulos, Evangelos Terpos, Mario Boccadoro, et al.
Blood Cancer Discovery
|
June 2, 2022
Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
Faith E Davies, Charlotte Pawlyn, Saad Z Usmani, et al.
Page
of 18